Lack of an FDA indication should not limit access to appropriate treatment

Publication date: Available online 20 September 2018

Source: Journal of the American Academy of Dermatology

Author(s): Joerg Albrecht, Adewole S. Adamson, John Barbieri, Daniel D. Bennett, Elizabeth A. Kiracofe, A. Shadi Kourosh, Kieron S. Leslie, Joseph F. Merola, Josephine Nguyen, Elaine Siegfried, Nicole Strickland, Suzanne Olbricht, Maryam M. Asgari, AADA Task Force on Drug Pricing and Transparency

https://ift.tt/2QLrzwz